WHC is still in active development. Read this to understand our approach.
depiction of HUNXMJYCHXQEGX-UHFFFAOYSA-N.svg
tripsit

sonata

Check on tripsit

psychonaut

Zaleplon

Check on psychonaut

isomerdesign

Zaleplon

Check on isomerdesign

drugmap

Zaleplon

Check on drugmap

wiki

Zaleplon

Check on wiki

Data

InChI: InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3

Synonyms: NC00437,3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide,N-[3-(7-Cyano-1,5,9-triazabicyclo[4.3.0]nona-2,4,6,8-tetraen-2-yl)phenyl]-N-ethylacetamide,S62U433RMH, LJC-10846,AZ-007,ZALEPLON [INN],DSSTox_GSID_23748, L846,DB-015068, 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide, ZAL-846,CHEMBL1521, SKP-1041,Sonata,CL 284846,AC-2082, 3'-(3-Cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide, Starnoc (TN),HMS3713H08,Zaleplon 1.0 mg/ml in Methanol,zaleplon,L-846,319Z345,UNII-S62U433RMH,N-(3-{3-cyanopyrazolo[1,5-a]pyrimidin-7-yl}phenyl)-N-ethylacetamide,Tox21_111872_1, N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide,ZALEPLON [MART.],ZAL 846, Zerene,Staccato-zaleplon,Acetamide, N-(3-(3-cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethyl-,DSSTox_CID_3748,LJC-10846,A809159,NCGC00160525-01,BIDD:GT0046,N-(3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-N-ethylacetamide,N-[3-(Cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide,Zaleplon civ,D00530,ZALEPLON [VANDF],SMR000238180,Tox21_111872,CL-284846,Sonata (TN), Staccato-zaleplon,ZALEPLON [USAN], Zaleplon (JAN/USAN/INN), N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide,Zaleplon,AKOS000280863,ZAL-846,DSSTox_RID_77183,3'-(3-CYANOPYRAZOLO(1,5-.ALPHA.)PYRIMIDIN-7-YL)-N-ETHYLACETANILIDE, LJC 10846, CL 284846,Zaleplon solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,ACT04427,SKP-1041,CAS-151319-34-5,CAS_5719, Zalaplon,1007130-22-4,GTPL4345,ZINC6300,HMS2052J11,N-[3-(3-cyanopyrazolo-[1,5-a]-pyrimidin-7-yl)-phenyl]-N-ethyl acetamide,DEA No. 2781,ACETAMIDE, N-(3-(3-CYANOPYRAZOLO(1,5-.ALPHA.)PYRIMIDIN-7-YL)PHENYL)-N-ETHYL-,LJC 10846,ZALEPLON [MI],CL 284,846,Zaleplon AP,Zaleplon (JAN/USP/INN),N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide,MLS001424238,NSC_5719,N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide,HMS3394J11,SR-01000759426,C07484,Zaleplon [USAN:USP:INN:BAN], Sonata (TN),CCG-101187,Zaleplon, >=98% (HPLC), solid,SR-01000759426-3,BDBM86521, CL284,846, L-846,DTXSID5023748,N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide,NCGC00160525-02,ZALEPLON [EMA EPAR],ZALEPLON [WHO-DD],BCP21340,AB00640003_03, Zaleplon [USAN:INN],HY-14265,MLS000759451, L 846,CHEBI:10102,ZALEPLON [JAN],Zaleplon, United States Pharmacopeia (USP) Reference Standard,ZALEPLON CIV [USP-RS], AZ-007,Q145052,DB00962, CL-284846, CL 284,846,151319-34-5,SCHEMBL29118,Acetamide, N-(3-(3-cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)phenyl)-N-ethyl-,ZALEPLON [USP MONOGRAPH],3'-(3-Cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide,ZALEPLON [ORANGE BOOK],L846, ZAL 846,A12993,SS-4571

Estimated data

Solubility: -4.075 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 43.7% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.